The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Retroviral Rebound Syndrome after Cessation of Suppressive Antiretroviral Therapy in Three Patients with Chronic HIV Infection
Abstract
BACKGROUND: Although viral rebound follows cessation of suppressive antiretroviral therapy in chronic HIV infection, a viremic clinical syndrome has not been described. OBJECTIVE: To describe a retroviral syndrome associated with cessation of effective antiretroviral therapy in chronic HIV infection. DESIGN: Case reports. SETTING: Outpatient HIV specialty clinics in Seattle, Washington, and Boston, Massachusetts. PATIENTS: Three patients with chronic HIV infection who discontinued suppressive antiretroviral therapy. MEASUREMENTS: Clinical course, plasma HIV RNA levels, and CD4 cell counts before, during, and after cessation of antiretroviral therapy. RESULTS: Within 6 weeks after stopping antiretroviral therapy, each patient experienced a clinical illness that resembled a primary HIV syndrome. This coincided with a marked increase in HIV RNA level and, in two of three patients, a decrease in CD4 cell count. After antiretroviral therapy was restarted, each patient's symptoms rapidly resolved in association with resuppression of HIV RNA and increase in CD4 cell count or percentage. CONCLUSION: A retroviral rebound syndrome similar to that seen in primary HIV syndrome can occur in patients with chronic HIV infection after cessation of suppressive antiretroviral therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cessation of therapy in HIV is associated with a strong viral rebound to pre-therapeutic plasma viral loads [164,165,166]”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [166]
Citations
Cites
Clinical and epidemiologic features of primary HIV infection.
Schacker, T., Collier, A. C., Hughes, J., Shea, T., & Corey, L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-4-199608150-00001 · Cited by 703 · cited 2×
“Aseptic meningitis also occurs in nearly one quarter of patients with primary retroviral syndrome who seek medical attention (1).”
Background
Research works printed but not linked: 9
- 10.1001/jama.1997.03550010072043 · DOI
- 10.1056/NEJM199807023390107 · DOI
- Jubault V, 1998, AIDS, 12, 2358
- 10.1097/00002030-199811000-00028 · DOI
- 10.1097/00002030-199905280-00001 · DOI
- 10.7326/0003-4819-128-10-199805150-00005 · DOI
- 10.1093/infdis/168.6.1490 · DOI
- 10.1128/jvi.68.7.4650-4655.1994 · DOI
- 10.1128/jvi.68.9.6103-6110.1994 · DOI
Cited by
Sorted by citations
Current State of Therapeutics for HTLV-1
Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22
“Amino acid sequence alignment of HTLV-1 and HIV-1 RT has shown that the two RTs share ~25% sequence identity and ~45% sequence similarity [73].”
Background
Metadata
- Authors
- Colven, R., Harrington, R. D., Spach, D. H., Cohen, C. J., & Hooton, T. M.
- Affiliations
- Harborview Medical Center (US)
- Corresponding author
- Colven, Roy
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2000-09-19
- Volume
- 133
- Issue
- 6
- Pages
- 430-434
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2009347249
- Cited by
- 63
- References
- 1
- Citations by year
- 2024: 3 · 2023: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 2
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- HIV infection, antiretroviral therapy discontinuation, viral rebound, CD4 count, plasma HIV RNA, chronic HIV infection
- MeSH terms
- Adult, Drug Therapy, Combination, Female, HIV, Humans, Male, Middle Aged, RNA, Viral, Syndrome, HIV Infections, Disease Progression, CD4 Lymphocyte Count, Anti-HIV Agents, Viral Load
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review